- Home
- REBN vs TXMD Comparison
REBN vs TXMD Comparison
Compare REBN & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REBN
- TXMD
- Stock Information
- Founded
- REBN 2015
- TXMD 2008
- Country
- REBN United States
- TXMD United States
- Employees
- REBN N/A
- TXMD N/A
- Industry
- REBN Restaurants
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- REBN Consumer Discretionary
- TXMD Health Care
- Exchange
- REBN Nasdaq
- TXMD Nasdaq
- Market Cap
- REBN 13.3M
- TXMD 12.3M
- IPO Year
- REBN 2022
- TXMD N/A
- Fundamental
- Price
- REBN $1.84
- TXMD $1.19
- Analyst Decision
- REBN
- TXMD
- Analyst Count
- REBN 0
- TXMD 0
- Target Price
- REBN N/A
- TXMD N/A
- AVG Volume (30 Days)
- REBN 84.4K
- TXMD 511.6K
- Earning Date
- REBN 11-18-2025
- TXMD 11-12-2025
- Dividend Yield
- REBN N/A
- TXMD N/A
- EPS Growth
- REBN N/A
- TXMD N/A
- EPS
- REBN N/A
- TXMD N/A
- Revenue
- REBN $6,565,623.00
- TXMD $2,559,000.00
- Revenue This Year
- REBN $335.98
- TXMD $427.09
- Revenue Next Year
- REBN N/A
- TXMD N/A
- P/E Ratio
- REBN N/A
- TXMD N/A
- Revenue Growth
- REBN 14.03
- TXMD 156.93
- 52 Week Low
- REBN $1.03
- TXMD $0.70
- 52 Week High
- REBN $8.30
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- REBN 27.55
- TXMD 53.55
- Support Level
- REBN $2.14
- TXMD $1.19
- Resistance Level
- REBN $2.37
- TXMD $1.28
- Average True Range (ATR)
- REBN 0.13
- TXMD 0.13
- MACD
- REBN -0.02
- TXMD 0.01
- Stochastic Oscillator
- REBN 0.00
- TXMD 23.88
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.